GB922029A - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
GB922029A
GB922029A GB17650/60A GB1765060A GB922029A GB 922029 A GB922029 A GB 922029A GB 17650/60 A GB17650/60 A GB 17650/60A GB 1765060 A GB1765060 A GB 1765060A GB 922029 A GB922029 A GB 922029A
Authority
GB
United Kingdom
Prior art keywords
liquid
sedative
compositions
salt
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17650/60A
Other languages
English (en)
Inventor
Henri Marie Laborit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EQUILIBRE BIOLOG L
Original Assignee
EQUILIBRE BIOLOG L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EQUILIBRE BIOLOG L filed Critical EQUILIBRE BIOLOG L
Priority to GB17650/60A priority Critical patent/GB922029A/en
Priority to FR842819A priority patent/FR791M/fr
Priority to BE603630A priority patent/BE603630A/fr
Publication of GB922029A publication Critical patent/GB922029A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB17650/60A 1960-05-19 1960-05-19 Therapeutic composition Expired GB922029A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB17650/60A GB922029A (en) 1960-05-19 1960-05-19 Therapeutic composition
FR842819A FR791M (US20050192411A1-20050901-C00001.png) 1960-05-19 1960-11-02
BE603630A BE603630A (fr) 1960-05-19 1961-05-10 Composition thérapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17650/60A GB922029A (en) 1960-05-19 1960-05-19 Therapeutic composition

Publications (1)

Publication Number Publication Date
GB922029A true GB922029A (en) 1963-03-27

Family

ID=10098877

Family Applications (1)

Application Number Title Priority Date Filing Date
GB17650/60A Expired GB922029A (en) 1960-05-19 1960-05-19 Therapeutic composition

Country Status (3)

Country Link
BE (1) BE603630A (US20050192411A1-20050901-C00001.png)
FR (1) FR791M (US20050192411A1-20050901-C00001.png)
GB (1) GB922029A (US20050192411A1-20050901-C00001.png)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044801A1 (de) * 1980-07-17 1982-01-27 Josef Dr. Klosa Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel
WO2000038672A2 (en) * 1998-12-23 2000-07-06 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
EP1316309A1 (en) * 1998-12-23 2003-06-04 Orphan Medical Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
US8772306B1 (en) 2013-03-01 2014-07-08 Jazz Pharmaceuticals, Inc. Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
WO2020106735A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
US10758488B2 (en) 2010-03-24 2020-09-01 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11426373B2 (en) 2017-03-17 2022-08-30 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11839597B2 (en) 2016-07-22 2023-12-12 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968233A (en) * 1973-12-05 1976-07-06 Istituto Chemioterapico Italiano α-Amino-γ-butyrolactones as sedatives

Cited By (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044801A1 (de) * 1980-07-17 1982-01-27 Josef Dr. Klosa Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel
US4393236A (en) * 1980-07-17 1983-07-12 Joseph Klosa Production of nonhygroscopic salts of 4-hydroxybutyric acid
US8324275B2 (en) 1998-12-23 2012-12-04 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8859619B2 (en) 1998-12-23 2014-10-14 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US6472431B2 (en) 1998-12-23 2002-10-29 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
WO2000038672A2 (en) * 1998-12-23 2000-07-06 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US6780889B2 (en) 1998-12-23 2004-08-24 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US9539330B2 (en) 1998-12-23 2017-01-10 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US7851506B2 (en) 1998-12-23 2010-12-14 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US7262219B2 (en) 1998-12-23 2007-08-28 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8263650B2 (en) 1998-12-23 2012-09-11 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8461203B2 (en) 1998-12-23 2013-06-11 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
EP1316309A1 (en) * 1998-12-23 2003-06-04 Orphan Medical Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
WO2000038672A3 (en) * 1998-12-23 2000-11-09 Orphan Medical Inc Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8952062B2 (en) 1998-12-23 2015-02-10 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
US9795567B2 (en) 2008-11-04 2017-10-24 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US11090269B1 (en) 2010-03-24 2021-08-17 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10987310B2 (en) 2010-03-24 2021-04-27 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10966931B2 (en) 2010-03-24 2021-04-06 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10959956B2 (en) 2010-03-24 2021-03-30 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10813885B1 (en) 2010-03-24 2020-10-27 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US11207270B2 (en) 2010-03-24 2021-12-28 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10758488B2 (en) 2010-03-24 2020-09-01 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US10675258B2 (en) 2012-12-14 2020-06-09 Jazz Pharmaceuticals Ireland Limited Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
US8901173B2 (en) 2012-12-14 2014-12-02 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US10195168B2 (en) 2012-12-14 2019-02-05 Jazz Pharmaceuticlas Ireland Limited Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
US11554102B2 (en) 2012-12-14 2023-01-17 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
US9132107B2 (en) 2012-12-14 2015-09-15 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9555017B2 (en) 2012-12-14 2017-01-31 Jazz Pharmaceuticals Ireland Limited Methods of making a mixture of salts of gamma-hydroxybutyrate
US9486426B2 (en) 2013-03-01 2016-11-08 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
EP3695833A1 (en) 2013-03-01 2020-08-19 Jazz Pharmaceuticals Ireland Limited Administration of gamma hydroxybutyrate with monocarboxylate transporters
US11986446B2 (en) 2013-03-01 2024-05-21 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
WO2014134380A1 (en) 2013-03-01 2014-09-04 Jazz Pharmaceuticals, Inc. Administration of gamma hydroxybutyrate with monocarboxylate transporters
US10864181B2 (en) 2013-03-01 2020-12-15 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US9050302B2 (en) 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US8772306B1 (en) 2013-03-01 2014-07-08 Jazz Pharmaceuticals, Inc. Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US8952029B2 (en) 2013-03-01 2015-02-10 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US10213400B2 (en) 2013-03-01 2019-02-26 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
EP3335708A1 (en) 2013-03-01 2018-06-20 Jazz Pharmaceuticals Ireland Limited Administration of gamma hydroxybutyrate with monocarboxylate transporters
US11253494B2 (en) 2013-03-01 2022-02-22 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11077079B1 (en) 2015-02-18 2021-08-03 Jazz Pharmaceuticals Ireland Limited GHB formulation and method for its manufacture
US11364215B1 (en) 2015-02-18 2022-06-21 Jazz Pharmaceuticals Ireland Limited GHB formulation and method for its manufacture
US11147782B1 (en) 2015-02-18 2021-10-19 Jazz Pharmaceuticals Ireland Limited GHB formulation and method for its manufacture
US11826335B2 (en) 2016-07-22 2023-11-28 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11839597B2 (en) 2016-07-22 2023-12-12 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11896572B2 (en) 2016-07-22 2024-02-13 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11766418B2 (en) 2016-07-22 2023-09-26 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11426373B2 (en) 2017-03-17 2022-08-30 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11400052B2 (en) 2018-11-19 2022-08-02 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
WO2020106735A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Also Published As

Publication number Publication date
FR791M (US20050192411A1-20050901-C00001.png) 1961-09-11
BE603630A (fr) 1961-09-01

Similar Documents

Publication Publication Date Title
GB922029A (en) Therapeutic composition
GB992813A (en) Sterilization solution
GB2000025A (en) Nitroimidazole formulations
FR2066096A5 (en) Cleansing agent for solid surfaces
ATE667T1 (de) Vaginales kontrazeptivum.
GB1068650A (en) Novel propane-carbamates,processes for preparing them,and compositions containing them
GB1252399A (US20050192411A1-20050901-C00001.png)
GB942964A (en) Purification of butynediol
GB1100443A (en) 17ª‡-chloroethynyl-13ª‰-ethylgonenolone
GB909365A (en) Orally ingestible solid penicillin compositions
JPS5238506A (en) Detergent composition
SE7613849L (sv) For injicering ferdigstellda losningar
FR1601724A (en) Drug aluminium chelates
GB1027058A (en) Dispersions of anaesthetics for injection
AU241270B2 (en) Thickened nitric acid for'use in-explosive compositions
BE759304Q (en) Phenoxyalkylamines coronary vasodilators and
ES395083A1 (es) Un procedimiento para la preparacion de los acidos 7-(d- (alfa-amino-alfa-fenila-cetamido))-3-cefem-4-carboxilicos 3 - sustituidos.
GB936902A (en) Quinazolinone derivatives
AU6170760A (en) Thickened nitric acid for'use in-explosive compositions
AU456961A (en) Therapeutic composition containing 4-hydroxybutyric acid or salts thereof
GB931019A (en) Pharmaceutical compositions containing quinazolone compounds
GB956231A (en) Improvements in or relating to derivatives of nitrofuran
FR1371M (fr) Sels alcalins de l'acide glycyrrhizique pur utilisables en thérapeutique.
GB920286A (en) Pharmaceutical composition having anti-tubercular action
FR1304913A (fr) Procédé de préparation de dérivés d'alcool polyvinylique contenant de l'azote